Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1621 to 1635 of 7691 results

  1. Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast (DG37)

    Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are

    Diagnostics guidance
    Published
    13 November 2019
    View recommendations

    Sections for DG37

  2. Testing strategies for Lynch syndrome in people with endometrial cancer (DG42)

    Evidence-based recommendations on testing strategies for Lynch syndrome for people with endometrial cancer

    Diagnostics guidance
    Published
    28 October 2020
    View recommendations

    Sections for DG42

  3. SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea (DG44)

    Evidence-based recommendations on SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea

    Diagnostics guidance
    Published
    17 November 2021
    View recommendations

    Sections for DG44

  4. PredictSURE IBD and IBDX to guide treatment of Crohn's disease (DG45)

    Evidence-based recommendations on PredictSURE IBD and IBDX for guiding treatment of Crohn’s disease

    Diagnostics guidance
    Published
    23 February 2022
    View recommendations

    Sections for DG45

  5. EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules (DG46)

    Evidence-based recommendations on EarlyCDT Lung for assessing the risk of lung cancer in solid lung nodules

    Diagnostics guidance
    Published
    23 February 2022
    View recommendations

    Sections for DG46

  6. FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (DG48)

    Evidence-based recommendations on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care

    Diagnostics guidance
    Published
    7 June 2023
    View recommendations

    Sections for DG48

  7. PLGF-based testing to help diagnose suspected preterm pre-eclampsia (DG49)

    Evidence-based recommendations on placental growth factor (PLGF)-based testing to help diagnose suspected preterm pre-eclampsia. The tests are: DELFIA Xpress PLGF 1 2 3, DELFIA Xpress sFlt 1/PLGF 1 2 3 ratio, Elecsys immunoassay sFlt 1/PLGF ratio, Triage PLGF Test

    Diagnostics guidance
    Published
    27 July 2022
    View recommendations

    Sections for DG49

  8. PneuX to prevent ventilator-associated pneumonia (MTG48)

    Evidence-based recommendations on PneuX to prevent ventilator-associated pneumonia.

    Medical technologies guidance
    Published
    8 April 2020
    View recommendations

    Sections for MTG48

  9. Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (MTG49)

    Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia.

    Medical technologies guidance
    Published
    24 June 2020
    View recommendations

    Sections for MTG49

  10. Axonics sacral neuromodulation system for treating refractory overactive bladder (MTG50)

    Evidence-based recommendations on Axonics sacral neuromodulation system for treating refractory overactive bladder.

    Medical technologies guidance
    Published
    3 September 2020
    View recommendations

    Sections for MTG50

  11. SEM Scanner 200 for preventing pressure ulcers (MTG51)

    Evidence-based recommendations on SEM Scanner 200 for preventing pressure ulcers.

    Medical technologies guidance
    Published
    14 October 2020
    View recommendations

    Sections for MTG51

  12. Zio XT for detecting cardiac arrhythmias (MTG52)

    Evidence-based recommendations on Zio XT for detecting cardiac arrhythmias.

    Medical technologies guidance
    Published
    1 December 2020
    View recommendations

    Sections for MTG52

  13. Synergo for non-muscle-invasive bladder cancer (MTG61)

    Evidence-based recommendations on Synergo for non-muscle-invasive bladder cancer.

    Medical technologies guidance
    Published
    30 November 2021
    View recommendations

    Sections for MTG61

  14. ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections (MTG62)

    Evidence-based recommendations on ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections.

    Medical technologies guidance
    Published
    13 December 2021
    View recommendations

    Sections for MTG62

  15. Endo-SPONGE for treating low rectal anastomotic leak (MTG63)

    Evidence-based recommendations on Endo-SPONGE for treating low rectal anastomotic leak.

    Medical technologies guidance
    Published
    16 December 2021
    View recommendations

    Sections for MTG63